Brain Aging: Muscle-to-brain Axis Modulates Physio-cognitive Decline
Age-related Cognitive Decline, Age-related Physiology Decline
About this trial
This is an interventional treatment trial for Age-related Cognitive Decline focused on measuring frailty, cognitive impairment, physio-cognitive decline syndrome, dementia, biomarkers, skeletal muscle, aging, neuroimaging, multidomain intervention
Eligibility Criteria
Inclusion Criteria: aged ≥ 65 years slow gait speed (<1 m/s in 6-meter walk test) or weakness (dominant handgrip strength <28 kg in men, <18 kg in women) subjective cognitive declines Exclusion Criteria: established diagnosis of dementia, Parkinsonism or other mobility-limiting conditions active diseases receiving treatment, such as cancer, heart failure, COPD and so on estimated life expectancy <12 months current nursing home residents
Sites / Locations
- Center for Healthy Longevity and Aging Sciences, National Yang Ming Chiao Tung University
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Usual care group
Multidomain intervention group
Provide conventional health educations in every three-month interval
The multidomain intervention program is designed as structural training sessions of 2-hour training sessions two times per week.